nodes	percent_of_prediction	percent_of_DWPC	metapath
Testosterone Propionate—UGT1A1—Irinotecan—colon cancer	0.503	1	CbGbCtD
Testosterone Propionate—AR—scrotum—colon cancer	0.056	0.382	CbGeAlD
Testosterone Propionate—Application site burn—Fluorouracil—colon cancer	0.0128	0.0575	CcSEcCtD
Testosterone Propionate—AR—Regulation of Androgen receptor activity—SPDEF—colon cancer	0.00985	0.0789	CbGpPWpGaD
Testosterone Propionate—CYP17A1—renal system—colon cancer	0.00768	0.0525	CbGeAlD
Testosterone Propionate—COMT—Metapathway biotransformation—CHST4—colon cancer	0.00742	0.0594	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metapathway biotransformation—CHST4—colon cancer	0.0071	0.0569	CbGpPWpGaD
Testosterone Propionate—UGT1A1—renal system—colon cancer	0.00702	0.048	CbGeAlD
Testosterone Propionate—Oligospermia—Methotrexate—colon cancer	0.00666	0.0299	CcSEcCtD
Testosterone Propionate—UGT1A1—Codeine and Morphine Metabolism—ABCB1—colon cancer	0.00636	0.051	CbGpPWpGaD
Testosterone Propionate—Application site pain—Fluorouracil—colon cancer	0.0061	0.0274	CcSEcCtD
Testosterone Propionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDX1—colon cancer	0.00603	0.0483	CbGpPWpGaD
Testosterone Propionate—COMT—smooth muscle tissue—colon cancer	0.00583	0.0398	CbGeAlD
Testosterone Propionate—UGT1A1—digestive system—colon cancer	0.00576	0.0393	CbGeAlD
Testosterone Propionate—COMT—renal system—colon cancer	0.00562	0.0384	CbGeAlD
Testosterone Propionate—Cognitive impairment—Methotrexate—colon cancer	0.00534	0.024	CcSEcCtD
Testosterone Propionate—Azoospermia—Methotrexate—colon cancer	0.00518	0.0233	CcSEcCtD
Testosterone Propionate—CYP17A1—liver—colon cancer	0.00469	0.0321	CbGeAlD
Testosterone Propionate—COMT—digestive system—colon cancer	0.00461	0.0315	CbGeAlD
Testosterone Propionate—UGT1A1—Metapathway biotransformation—CHST4—colon cancer	0.00444	0.0356	CbGpPWpGaD
Testosterone Propionate—AR—epithelium—colon cancer	0.00443	0.0303	CbGeAlD
Testosterone Propionate—UGT1A1—liver—colon cancer	0.00429	0.0293	CbGeAlD
Testosterone Propionate—AR—smooth muscle tissue—colon cancer	0.00427	0.0292	CbGeAlD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—RAD54L—colon cancer	0.00426	0.0342	CbGpPWpGaD
Testosterone Propionate—COMT—bone marrow—colon cancer	0.00425	0.029	CbGeAlD
Testosterone Propionate—AR—renal system—colon cancer	0.00411	0.0281	CbGeAlD
Testosterone Propionate—COMT—vagina—colon cancer	0.00407	0.0278	CbGeAlD
Testosterone Propionate—CYP17A1—lymph node—colon cancer	0.0036	0.0246	CbGeAlD
Testosterone Propionate—COMT—liver—colon cancer	0.00343	0.0234	CbGeAlD
Testosterone Propionate—AR—lymphoid tissue—colon cancer	0.00341	0.0233	CbGeAlD
Testosterone Propionate—COMT—Metapathway biotransformation—CHST5—colon cancer	0.00341	0.0273	CbGpPWpGaD
Testosterone Propionate—AR—digestive system—colon cancer	0.00337	0.023	CbGeAlD
Testosterone Propionate—AR—Nuclear Receptors—HNF4A—colon cancer	0.0033	0.0264	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metapathway biotransformation—CHST5—colon cancer	0.00326	0.0261	CbGpPWpGaD
Testosterone Propionate—Cognitive disorder—Methotrexate—colon cancer	0.00322	0.0145	CcSEcCtD
Testosterone Propionate—Hirsutism—Capecitabine—colon cancer	0.00322	0.0145	CcSEcCtD
Testosterone Propionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—AXIN2—colon cancer	0.00309	0.0247	CbGpPWpGaD
Testosterone Propionate—AR—vagina—colon cancer	0.00298	0.0203	CbGeAlD
Testosterone Propionate—UGT1A1—Irinotecan Pathway—APC—colon cancer	0.00293	0.0235	CbGpPWpGaD
Testosterone Propionate—Inflammation—Fluorouracil—colon cancer	0.00276	0.0124	CcSEcCtD
Testosterone Propionate—COMT—lymph node—colon cancer	0.00263	0.018	CbGeAlD
Testosterone Propionate—AR—Nuclear Receptor transcription pathway—HNF4A—colon cancer	0.00261	0.0209	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—ODC1—colon cancer	0.00258	0.0207	CbGpPWpGaD
Testosterone Propionate—Neoplasm—Irinotecan—colon cancer	0.00253	0.0114	CcSEcCtD
Testosterone Propionate—AR—liver—colon cancer	0.00251	0.0172	CbGeAlD
Testosterone Propionate—Coagulopathy—Capecitabine—colon cancer	0.00241	0.0108	CcSEcCtD
Testosterone Propionate—Anaphylactoid reaction—Irinotecan—colon cancer	0.0021	0.00944	CcSEcCtD
Testosterone Propionate—UGT1A1—Constitutive Androstane Receptor Pathway—ABCB1—colon cancer	0.0021	0.0168	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metapathway biotransformation—CHST5—colon cancer	0.00204	0.0163	CbGpPWpGaD
Testosterone Propionate—Dermatitis bullous—Fluorouracil—colon cancer	0.00204	0.00916	CcSEcCtD
Testosterone Propionate—Gastrointestinal haemorrhage—Irinotecan—colon cancer	0.00203	0.00914	CcSEcCtD
Testosterone Propionate—Gastrointestinal haemorrhage—Fluorouracil—colon cancer	0.00195	0.00875	CcSEcCtD
Testosterone Propionate—Inflammation—Capecitabine—colon cancer	0.00193	0.00869	CcSEcCtD
Testosterone Propionate—AR—lymph node—colon cancer	0.00193	0.0131	CbGeAlD
Testosterone Propionate—Irritability—Fluorouracil—colon cancer	0.00186	0.00835	CcSEcCtD
Testosterone Propionate—AR—Regulation of nuclear SMAD2/3 signaling—HNF4A—colon cancer	0.0018	0.0144	CbGpPWpGaD
Testosterone Propionate—Neoplasm—Capecitabine—colon cancer	0.00169	0.00762	CcSEcCtD
Testosterone Propionate—Dysuria—Vincristine—colon cancer	0.00169	0.00758	CcSEcCtD
Testosterone Propionate—Erectile dysfunction—Vincristine—colon cancer	0.00166	0.00747	CcSEcCtD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—TOP1—colon cancer	0.00158	0.0126	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Aryl Hydrocarbon Receptor Pathway—BAX—colon cancer	0.00149	0.0119	CbGpPWpGaD
Testosterone Propionate—Libido decreased—Capecitabine—colon cancer	0.00147	0.0066	CcSEcCtD
Testosterone Propionate—Increased appetite—Capecitabine—colon cancer	0.00145	0.00651	CcSEcCtD
Testosterone Propionate—Inflammation—Methotrexate—colon cancer	0.00144	0.00647	CcSEcCtD
Testosterone Propionate—AR—Nuclear Receptors—PPARG—colon cancer	0.00143	0.0115	CbGpPWpGaD
Testosterone Propionate—Urinary tract disorder—Vincristine—colon cancer	0.00143	0.00641	CcSEcCtD
Testosterone Propionate—Dermatitis bullous—Capecitabine—colon cancer	0.00142	0.0064	CcSEcCtD
Testosterone Propionate—Connective tissue disorder—Vincristine—colon cancer	0.00142	0.00638	CcSEcCtD
Testosterone Propionate—Urethral disorder—Vincristine—colon cancer	0.00141	0.00636	CcSEcCtD
Testosterone Propionate—Haemoglobin—Irinotecan—colon cancer	0.00141	0.00635	CcSEcCtD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—MSH6—colon cancer	0.00141	0.0113	CbGpPWpGaD
Testosterone Propionate—Haemorrhage—Irinotecan—colon cancer	0.00141	0.00632	CcSEcCtD
Testosterone Propionate—Connective tissue disorder—Irinotecan—colon cancer	0.00138	0.00621	CcSEcCtD
Testosterone Propionate—Gastrointestinal haemorrhage—Capecitabine—colon cancer	0.00136	0.00612	CcSEcCtD
Testosterone Propionate—Haemoglobin—Fluorouracil—colon cancer	0.00135	0.00609	CcSEcCtD
Testosterone Propionate—Disturbance in sexual arousal—Capecitabine—colon cancer	0.00135	0.00607	CcSEcCtD
Testosterone Propionate—Haemorrhage—Fluorouracil—colon cancer	0.00135	0.00605	CcSEcCtD
Testosterone Propionate—Angiopathy—Vincristine—colon cancer	0.00131	0.00589	CcSEcCtD
Testosterone Propionate—Mediastinal disorder—Vincristine—colon cancer	0.0013	0.00585	CcSEcCtD
Testosterone Propionate—Irritability—Capecitabine—colon cancer	0.0013	0.00584	CcSEcCtD
Testosterone Propionate—Alopecia—Vincristine—colon cancer	0.00128	0.00574	CcSEcCtD
Testosterone Propionate—Angiopathy—Irinotecan—colon cancer	0.00128	0.00574	CcSEcCtD
Testosterone Propionate—Immune system disorder—Irinotecan—colon cancer	0.00127	0.00571	CcSEcCtD
Testosterone Propionate—Mediastinal disorder—Irinotecan—colon cancer	0.00127	0.0057	CcSEcCtD
Testosterone Propionate—Mental disorder—Vincristine—colon cancer	0.00126	0.00569	CcSEcCtD
Testosterone Propionate—Neoplasm—Methotrexate—colon cancer	0.00126	0.00567	CcSEcCtD
Testosterone Propionate—Liver function test abnormal—Capecitabine—colon cancer	0.00126	0.00565	CcSEcCtD
Testosterone Propionate—Gynaecomastia—Methotrexate—colon cancer	0.00125	0.00561	CcSEcCtD
Testosterone Propionate—Alopecia—Irinotecan—colon cancer	0.00124	0.00559	CcSEcCtD
Testosterone Propionate—Breast disorder—Capecitabine—colon cancer	0.00123	0.00553	CcSEcCtD
Testosterone Propionate—Alopecia—Fluorouracil—colon cancer	0.00119	0.00535	CcSEcCtD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—MSH2—colon cancer	0.00114	0.00914	CbGpPWpGaD
Testosterone Propionate—Ill-defined disorder—Irinotecan—colon cancer	0.00114	0.00511	CcSEcCtD
Testosterone Propionate—AR—Nuclear Receptor transcription pathway—PPARG—colon cancer	0.00113	0.00907	CbGpPWpGaD
Testosterone Propionate—Malaise—Irinotecan—colon cancer	0.0011	0.00496	CcSEcCtD
Testosterone Propionate—Dysuria—Capecitabine—colon cancer	0.0011	0.00494	CcSEcCtD
Testosterone Propionate—Hypertension—Vincristine—colon cancer	0.00108	0.00488	CcSEcCtD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—DCC—colon cancer	0.00108	0.00863	CbGpPWpGaD
Testosterone Propionate—AR—Nongenotropic Androgen signaling—SRC—colon cancer	0.00107	0.00859	CbGpPWpGaD
Testosterone Propionate—Myalgia—Vincristine—colon cancer	0.00107	0.00481	CcSEcCtD
Testosterone Propionate—Weight increased—Capecitabine—colon cancer	0.00107	0.00481	CcSEcCtD
Testosterone Propionate—Hypertension—Irinotecan—colon cancer	0.00106	0.00475	CcSEcCtD
Testosterone Propionate—Anaphylactoid reaction—Methotrexate—colon cancer	0.00105	0.0047	CcSEcCtD
Testosterone Propionate—Discomfort—Irinotecan—colon cancer	0.00103	0.00463	CcSEcCtD
Testosterone Propionate—Anaphylactic shock—Vincristine—colon cancer	0.00103	0.00461	CcSEcCtD
Testosterone Propionate—Oedema—Vincristine—colon cancer	0.00103	0.00461	CcSEcCtD
Testosterone Propionate—Confusional state—Irinotecan—colon cancer	0.00101	0.00453	CcSEcCtD
Testosterone Propionate—Nervous system disorder—Vincristine—colon cancer	0.00101	0.00452	CcSEcCtD
Testosterone Propionate—Haematuria—Capecitabine—colon cancer	0.000999	0.00449	CcSEcCtD
Testosterone Propionate—Oedema—Irinotecan—colon cancer	0.000999	0.00449	CcSEcCtD
Testosterone Propionate—Anaphylactic shock—Irinotecan—colon cancer	0.000999	0.00449	CcSEcCtD
Testosterone Propionate—Myalgia—Fluorouracil—colon cancer	0.000998	0.00449	CcSEcCtD
Testosterone Propionate—Hepatobiliary disease—Capecitabine—colon cancer	0.000991	0.00446	CcSEcCtD
Testosterone Propionate—Discomfort—Fluorouracil—colon cancer	0.000986	0.00443	CcSEcCtD
Testosterone Propionate—Nervous system disorder—Irinotecan—colon cancer	0.000979	0.0044	CcSEcCtD
Testosterone Propionate—COMT—Metabolism—CA7—colon cancer	0.000975	0.00781	CbGpPWpGaD
Testosterone Propionate—Irritability—Methotrexate—colon cancer	0.000966	0.00435	CcSEcCtD
Testosterone Propionate—Confusional state—Fluorouracil—colon cancer	0.000964	0.00434	CcSEcCtD
Testosterone Propionate—Oedema—Fluorouracil—colon cancer	0.000956	0.0043	CcSEcCtD
Testosterone Propionate—Anaphylactic shock—Fluorouracil—colon cancer	0.000956	0.0043	CcSEcCtD
Testosterone Propionate—Haemoglobin—Capecitabine—colon cancer	0.000946	0.00425	CcSEcCtD
Testosterone Propionate—Haemorrhage—Capecitabine—colon cancer	0.000941	0.00423	CcSEcCtD
Testosterone Propionate—Nervous system disorder—Fluorouracil—colon cancer	0.000938	0.00422	CcSEcCtD
Testosterone Propionate—Liver function test abnormal—Methotrexate—colon cancer	0.000935	0.0042	CcSEcCtD
Testosterone Propionate—Musculoskeletal discomfort—Vincristine—colon cancer	0.000934	0.0042	CcSEcCtD
Testosterone Propionate—CYP17A1—Metabolism—CA7—colon cancer	0.000933	0.00747	CbGpPWpGaD
Testosterone Propionate—Urinary tract disorder—Capecitabine—colon cancer	0.000929	0.00418	CcSEcCtD
Testosterone Propionate—Insomnia—Vincristine—colon cancer	0.000927	0.00417	CcSEcCtD
Testosterone Propionate—Connective tissue disorder—Capecitabine—colon cancer	0.000924	0.00416	CcSEcCtD
Testosterone Propionate—Urethral disorder—Capecitabine—colon cancer	0.000922	0.00415	CcSEcCtD
Testosterone Propionate—Paraesthesia—Vincristine—colon cancer	0.000921	0.00414	CcSEcCtD
Testosterone Propionate—Breast disorder—Methotrexate—colon cancer	0.000915	0.00411	CcSEcCtD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—HNF4A—colon cancer	0.000907	0.00726	CbGpPWpGaD
Testosterone Propionate—Insomnia—Irinotecan—colon cancer	0.000903	0.00406	CcSEcCtD
Testosterone Propionate—Paraesthesia—Irinotecan—colon cancer	0.000897	0.00403	CcSEcCtD
Testosterone Propionate—Dyspnoea—Irinotecan—colon cancer	0.00089	0.004	CcSEcCtD
Testosterone Propionate—Gastrointestinal disorder—Vincristine—colon cancer	0.000885	0.00398	CcSEcCtD
Testosterone Propionate—Fatigue—Vincristine—colon cancer	0.000884	0.00398	CcSEcCtD
Testosterone Propionate—Pain—Vincristine—colon cancer	0.000877	0.00394	CcSEcCtD
Testosterone Propionate—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.000871	0.00392	CcSEcCtD
Testosterone Propionate—Insomnia—Fluorouracil—colon cancer	0.000865	0.00389	CcSEcCtD
Testosterone Propionate—Gastrointestinal disorder—Irinotecan—colon cancer	0.000862	0.00388	CcSEcCtD
Testosterone Propionate—Fatigue—Irinotecan—colon cancer	0.000861	0.00387	CcSEcCtD
Testosterone Propionate—Paraesthesia—Fluorouracil—colon cancer	0.000859	0.00386	CcSEcCtD
Testosterone Propionate—Pain—Irinotecan—colon cancer	0.000854	0.00384	CcSEcCtD
Testosterone Propionate—Angiopathy—Capecitabine—colon cancer	0.000854	0.00384	CcSEcCtD
Testosterone Propionate—Dyspnoea—Fluorouracil—colon cancer	0.000853	0.00383	CcSEcCtD
Testosterone Propionate—Immune system disorder—Capecitabine—colon cancer	0.00085	0.00382	CcSEcCtD
Testosterone Propionate—Mediastinal disorder—Capecitabine—colon cancer	0.000848	0.00381	CcSEcCtD
Testosterone Propionate—Gastrointestinal pain—Vincristine—colon cancer	0.000839	0.00377	CcSEcCtD
Testosterone Propionate—AR—FOXA1 transcription factor network—EP300—colon cancer	0.000833	0.00668	CbGpPWpGaD
Testosterone Propionate—Alopecia—Capecitabine—colon cancer	0.000831	0.00374	CcSEcCtD
Testosterone Propionate—Drospirenone—PTGS2—colon cancer	0.000829	0.239	CrCbGaD
Testosterone Propionate—Gastrointestinal disorder—Fluorouracil—colon cancer	0.000826	0.00371	CcSEcCtD
Testosterone Propionate—Mental disorder—Capecitabine—colon cancer	0.000824	0.00371	CcSEcCtD
Testosterone Propionate—Feeling abnormal—Irinotecan—colon cancer	0.000823	0.0037	CcSEcCtD
Testosterone Propionate—Malnutrition—Capecitabine—colon cancer	0.000819	0.00368	CcSEcCtD
Testosterone Propionate—Dysuria—Methotrexate—colon cancer	0.000818	0.00368	CcSEcCtD
Testosterone Propionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—APC—colon cancer	0.000818	0.00655	CbGpPWpGaD
Testosterone Propionate—Pain—Fluorouracil—colon cancer	0.000818	0.00368	CcSEcCtD
Testosterone Propionate—Gastrointestinal pain—Irinotecan—colon cancer	0.000817	0.00367	CcSEcCtD
Testosterone Propionate—AR—Nongenotropic Androgen signaling—PIK3CA—colon cancer	0.000816	0.00653	CbGpPWpGaD
Testosterone Propionate—Abdominal pain—Vincristine—colon cancer	0.000811	0.00365	CcSEcCtD
Testosterone Propionate—Megestrol acetate—ABCB1—colon cancer	0.000808	0.233	CrCbGaD
Testosterone Propionate—Erectile dysfunction—Methotrexate—colon cancer	0.000806	0.00362	CcSEcCtD
Testosterone Propionate—AR—Notch-mediated HES/HEY network—EP300—colon cancer	0.000791	0.00633	CbGpPWpGaD
Testosterone Propionate—Abdominal pain—Irinotecan—colon cancer	0.000789	0.00355	CcSEcCtD
Testosterone Propionate—Feeling abnormal—Fluorouracil—colon cancer	0.000788	0.00354	CcSEcCtD
Testosterone Propionate—Ill-defined disorder—Capecitabine—colon cancer	0.00076	0.00342	CcSEcCtD
Testosterone Propionate—Urticaria—Fluorouracil—colon cancer	0.00076	0.00342	CcSEcCtD
Testosterone Propionate—Hypersensitivity—Vincristine—colon cancer	0.000756	0.0034	CcSEcCtD
Testosterone Propionate—AR—Nongenotropic Androgen signaling—HRAS—colon cancer	0.000755	0.00605	CbGpPWpGaD
Testosterone Propionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDH1—colon cancer	0.000753	0.00603	CbGpPWpGaD
Testosterone Propionate—Haematuria—Methotrexate—colon cancer	0.000744	0.00335	CcSEcCtD
Testosterone Propionate—Malaise—Capecitabine—colon cancer	0.000739	0.00332	CcSEcCtD
Testosterone Propionate—Hepatobiliary disease—Methotrexate—colon cancer	0.000738	0.00332	CcSEcCtD
Testosterone Propionate—Hypersensitivity—Irinotecan—colon cancer	0.000736	0.00331	CcSEcCtD
Testosterone Propionate—Asthenia—Vincristine—colon cancer	0.000736	0.00331	CcSEcCtD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—BUB1B—colon cancer	0.000725	0.0058	CbGpPWpGaD
Testosterone Propionate—AR—Regulation of Androgen receptor activity—EP300—colon cancer	0.000718	0.00575	CbGpPWpGaD
Testosterone Propionate—Asthenia—Irinotecan—colon cancer	0.000717	0.00322	CcSEcCtD
Testosterone Propionate—UGT1A1—Aryl Hydrocarbon Receptor Pathway—EP300—colon cancer	0.000715	0.00572	CbGpPWpGaD
Testosterone Propionate—Hypertension—Capecitabine—colon cancer	0.000707	0.00318	CcSEcCtD
Testosterone Propionate—Hypersensitivity—Fluorouracil—colon cancer	0.000705	0.00317	CcSEcCtD
Testosterone Propionate—Haemoglobin—Methotrexate—colon cancer	0.000704	0.00317	CcSEcCtD
Testosterone Propionate—Diarrhoea—Vincristine—colon cancer	0.000702	0.00316	CcSEcCtD
Testosterone Propionate—Haemorrhage—Methotrexate—colon cancer	0.0007	0.00315	CcSEcCtD
Testosterone Propionate—AR—Regulation of Androgen receptor activity—SRC—colon cancer	0.000698	0.00559	CbGpPWpGaD
Testosterone Propionate—Myalgia—Capecitabine—colon cancer	0.000697	0.00314	CcSEcCtD
Testosterone Propionate—Arthralgia—Capecitabine—colon cancer	0.000697	0.00314	CcSEcCtD
Testosterone Propionate—AR—Coregulation of Androgen receptor activity—CCND1—colon cancer	0.000697	0.00558	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Aryl Hydrocarbon Receptor Pathway—SRC—colon cancer	0.000695	0.00557	CbGpPWpGaD
Testosterone Propionate—Anxiety—Capecitabine—colon cancer	0.000695	0.00312	CcSEcCtD
Testosterone Propionate—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.000692	0.00311	CcSEcCtD
Testosterone Propionate—Urinary tract disorder—Methotrexate—colon cancer	0.000692	0.00311	CcSEcCtD
Testosterone Propionate—AR—Coregulation of Androgen receptor activity—CTNNB1—colon cancer	0.00069	0.00553	CbGpPWpGaD
Testosterone Propionate—Discomfort—Capecitabine—colon cancer	0.000689	0.0031	CcSEcCtD
Testosterone Propionate—Urethral disorder—Methotrexate—colon cancer	0.000687	0.00309	CcSEcCtD
Testosterone Propionate—Diarrhoea—Irinotecan—colon cancer	0.000683	0.00307	CcSEcCtD
Testosterone Propionate—Dizziness—Vincristine—colon cancer	0.000678	0.00305	CcSEcCtD
Testosterone Propionate—Pruritus—Fluorouracil—colon cancer	0.000677	0.00304	CcSEcCtD
Testosterone Propionate—Confusional state—Capecitabine—colon cancer	0.000674	0.00303	CcSEcCtD
Testosterone Propionate—Oedema—Capecitabine—colon cancer	0.000668	0.00301	CcSEcCtD
Testosterone Propionate—AR—Nongenotropic Androgen signaling—AKT1—colon cancer	0.000667	0.00534	CbGpPWpGaD
Testosterone Propionate—Dizziness—Irinotecan—colon cancer	0.00066	0.00297	CcSEcCtD
Testosterone Propionate—Nervous system disorder—Capecitabine—colon cancer	0.000655	0.00295	CcSEcCtD
Testosterone Propionate—Diarrhoea—Fluorouracil—colon cancer	0.000654	0.00294	CcSEcCtD
Testosterone Propionate—Vomiting—Vincristine—colon cancer	0.000652	0.00293	CcSEcCtD
Testosterone Propionate—Skin disorder—Capecitabine—colon cancer	0.000649	0.00292	CcSEcCtD
Testosterone Propionate—Rash—Vincristine—colon cancer	0.000647	0.00291	CcSEcCtD
Testosterone Propionate—Dermatitis—Vincristine—colon cancer	0.000646	0.0029	CcSEcCtD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—BAX—colon cancer	0.000646	0.00517	CbGpPWpGaD
Testosterone Propionate—Headache—Vincristine—colon cancer	0.000642	0.00289	CcSEcCtD
Testosterone Propionate—Angiopathy—Methotrexate—colon cancer	0.000635	0.00286	CcSEcCtD
Testosterone Propionate—Vomiting—Irinotecan—colon cancer	0.000635	0.00286	CcSEcCtD
Testosterone Propionate—Immune system disorder—Methotrexate—colon cancer	0.000633	0.00284	CcSEcCtD
Testosterone Propionate—Dizziness—Fluorouracil—colon cancer	0.000632	0.00284	CcSEcCtD
Testosterone Propionate—Mediastinal disorder—Methotrexate—colon cancer	0.000631	0.00284	CcSEcCtD
Testosterone Propionate—Rash—Irinotecan—colon cancer	0.00063	0.00283	CcSEcCtD
Testosterone Propionate—Dermatitis—Irinotecan—colon cancer	0.000629	0.00283	CcSEcCtD
Testosterone Propionate—Headache—Irinotecan—colon cancer	0.000626	0.00281	CcSEcCtD
Testosterone Propionate—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—colon cancer	0.000621	0.00498	CbGpPWpGaD
Testosterone Propionate—Alopecia—Methotrexate—colon cancer	0.000619	0.00278	CcSEcCtD
Testosterone Propionate—Mental disorder—Methotrexate—colon cancer	0.000614	0.00276	CcSEcCtD
Testosterone Propionate—Malnutrition—Methotrexate—colon cancer	0.00061	0.00274	CcSEcCtD
Testosterone Propionate—Nausea—Vincristine—colon cancer	0.000609	0.00274	CcSEcCtD
Testosterone Propionate—UGT1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—colon cancer	0.000609	0.00488	CbGpPWpGaD
Testosterone Propionate—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000609	0.00274	CcSEcCtD
Testosterone Propionate—Vomiting—Fluorouracil—colon cancer	0.000608	0.00273	CcSEcCtD
Testosterone Propionate—Insomnia—Capecitabine—colon cancer	0.000605	0.00272	CcSEcCtD
Testosterone Propionate—Rash—Fluorouracil—colon cancer	0.000603	0.00271	CcSEcCtD
Testosterone Propionate—Dermatitis—Fluorouracil—colon cancer	0.000603	0.00271	CcSEcCtD
Testosterone Propionate—Paraesthesia—Capecitabine—colon cancer	0.0006	0.0027	CcSEcCtD
Testosterone Propionate—Headache—Fluorouracil—colon cancer	0.000599	0.00269	CcSEcCtD
Testosterone Propionate—Dyspnoea—Capecitabine—colon cancer	0.000596	0.00268	CcSEcCtD
Testosterone Propionate—Nausea—Irinotecan—colon cancer	0.000593	0.00267	CcSEcCtD
Testosterone Propionate—COMT—Metabolism—CHST5—colon cancer	0.00059	0.00473	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—ODC1—colon cancer	0.00059	0.00473	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—CA7—colon cancer	0.000584	0.00468	CbGpPWpGaD
Testosterone Propionate—Gastrointestinal disorder—Capecitabine—colon cancer	0.000577	0.0026	CcSEcCtD
Testosterone Propionate—Fatigue—Capecitabine—colon cancer	0.000576	0.00259	CcSEcCtD
Testosterone Propionate—Pain—Capecitabine—colon cancer	0.000572	0.00257	CcSEcCtD
Testosterone Propionate—Nausea—Fluorouracil—colon cancer	0.000568	0.00255	CcSEcCtD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—ABCB1—colon cancer	0.000566	0.00453	CbGpPWpGaD
Testosterone Propionate—Ill-defined disorder—Methotrexate—colon cancer	0.000566	0.00254	CcSEcCtD
Testosterone Propionate—CYP17A1—Metabolism—ODC1—colon cancer	0.000565	0.00453	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—CHST5—colon cancer	0.000565	0.00453	CbGpPWpGaD
Testosterone Propionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CCND1—colon cancer	0.000561	0.00449	CbGpPWpGaD
Testosterone Propionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CTNNB1—colon cancer	0.000556	0.00445	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—TYMS—colon cancer	0.000556	0.00445	CbGpPWpGaD
Testosterone Propionate—Feeling abnormal—Capecitabine—colon cancer	0.000551	0.00248	CcSEcCtD
Testosterone Propionate—Malaise—Methotrexate—colon cancer	0.00055	0.00247	CcSEcCtD
Testosterone Propionate—COMT—Transmission across Chemical Synapses—BRAF—colon cancer	0.000548	0.00439	CbGpPWpGaD
Testosterone Propionate—Gastrointestinal pain—Capecitabine—colon cancer	0.000547	0.00246	CcSEcCtD
Testosterone Propionate—AR—Regulation of nuclear SMAD2/3 signaling—CDKN1A—colon cancer	0.000538	0.00431	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—BAX—colon cancer	0.000535	0.00429	CbGpPWpGaD
Testosterone Propionate—Urticaria—Capecitabine—colon cancer	0.000531	0.00239	CcSEcCtD
Testosterone Propionate—Abdominal pain—Capecitabine—colon cancer	0.000528	0.00238	CcSEcCtD
Testosterone Propionate—Myalgia—Methotrexate—colon cancer	0.000519	0.00233	CcSEcCtD
Testosterone Propionate—Arthralgia—Methotrexate—colon cancer	0.000519	0.00233	CcSEcCtD
Testosterone Propionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—EP300—colon cancer	0.000517	0.00414	CbGpPWpGaD
Testosterone Propionate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.000515	0.00232	CcSEcCtD
Testosterone Propionate—AR—Androgen receptor signaling pathway—CCND1—colon cancer	0.000515	0.00413	CbGpPWpGaD
Testosterone Propionate—Discomfort—Methotrexate—colon cancer	0.000513	0.00231	CcSEcCtD
Testosterone Propionate—AR—Regulation of nuclear SMAD2/3 signaling—EP300—colon cancer	0.000512	0.0041	CbGpPWpGaD
Testosterone Propionate—AR—Androgen receptor signaling pathway—CTNNB1—colon cancer	0.00051	0.00409	CbGpPWpGaD
Testosterone Propionate—Spironolactone—ABCB1—colon cancer	0.000502	0.145	CrCbGaD
Testosterone Propionate—Confusional state—Methotrexate—colon cancer	0.000502	0.00226	CcSEcCtD
Testosterone Propionate—AR—Androgen receptor signaling pathway—CDKN1A—colon cancer	0.000499	0.00399	CbGpPWpGaD
Testosterone Propionate—Anaphylactic shock—Methotrexate—colon cancer	0.000498	0.00224	CcSEcCtD
Testosterone Propionate—Hypersensitivity—Capecitabine—colon cancer	0.000492	0.00221	CcSEcCtD
Testosterone Propionate—Nervous system disorder—Methotrexate—colon cancer	0.000488	0.00219	CcSEcCtD
Testosterone Propionate—Skin disorder—Methotrexate—colon cancer	0.000483	0.00217	CcSEcCtD
Testosterone Propionate—Asthenia—Capecitabine—colon cancer	0.00048	0.00216	CcSEcCtD
Testosterone Propionate—AR—Androgen receptor signaling pathway—EP300—colon cancer	0.000474	0.0038	CbGpPWpGaD
Testosterone Propionate—Pruritus—Capecitabine—colon cancer	0.000473	0.00213	CcSEcCtD
Testosterone Propionate—Norethindrone—ABCB1—colon cancer	0.000466	0.134	CrCbGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—BRAF—colon cancer	0.000463	0.00371	CbGpPWpGaD
Testosterone Propionate—AR—Androgen receptor signaling pathway—SRC—colon cancer	0.000461	0.00369	CbGpPWpGaD
Testosterone Propionate—Diarrhoea—Capecitabine—colon cancer	0.000457	0.00206	CcSEcCtD
Testosterone Propionate—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000453	0.00204	CcSEcCtD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—CDH1—colon cancer	0.000453	0.00363	CbGpPWpGaD
Testosterone Propionate—AR—Generic Transcription Pathway—HNF4A—colon cancer	0.00045	0.00361	CbGpPWpGaD
Testosterone Propionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—colon cancer	0.00045	0.00361	CbGpPWpGaD
Testosterone Propionate—Insomnia—Methotrexate—colon cancer	0.00045	0.00202	CcSEcCtD
Testosterone Propionate—Paraesthesia—Methotrexate—colon cancer	0.000447	0.00201	CcSEcCtD
Testosterone Propionate—AR—Regulation of nuclear SMAD2/3 signaling—MYC—colon cancer	0.000446	0.00357	CbGpPWpGaD
Testosterone Propionate—Dyspnoea—Methotrexate—colon cancer	0.000444	0.00199	CcSEcCtD
Testosterone Propionate—Dizziness—Capecitabine—colon cancer	0.000442	0.00199	CcSEcCtD
Testosterone Propionate—Gastrointestinal disorder—Methotrexate—colon cancer	0.00043	0.00193	CcSEcCtD
Testosterone Propionate—Fatigue—Methotrexate—colon cancer	0.000429	0.00193	CcSEcCtD
Testosterone Propionate—Pain—Methotrexate—colon cancer	0.000425	0.00191	CcSEcCtD
Testosterone Propionate—Vomiting—Capecitabine—colon cancer	0.000425	0.00191	CcSEcCtD
Testosterone Propionate—Rash—Capecitabine—colon cancer	0.000421	0.0019	CcSEcCtD
Testosterone Propionate—Dermatitis—Capecitabine—colon cancer	0.000421	0.00189	CcSEcCtD
Testosterone Propionate—COMT—Neuronal System—BRAF—colon cancer	0.00042	0.00336	CbGpPWpGaD
Testosterone Propionate—Headache—Capecitabine—colon cancer	0.000419	0.00188	CcSEcCtD
Testosterone Propionate—Feeling abnormal—Methotrexate—colon cancer	0.00041	0.00184	CcSEcCtD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—APC—colon cancer	0.000408	0.00327	CbGpPWpGaD
Testosterone Propionate—Gastrointestinal pain—Methotrexate—colon cancer	0.000407	0.00183	CcSEcCtD
Testosterone Propionate—AR—Androgen receptor signaling pathway—EGFR—colon cancer	0.000404	0.00324	CbGpPWpGaD
Testosterone Propionate—Nausea—Capecitabine—colon cancer	0.000397	0.00179	CcSEcCtD
Testosterone Propionate—Urticaria—Methotrexate—colon cancer	0.000395	0.00178	CcSEcCtD
Testosterone Propionate—Abdominal pain—Methotrexate—colon cancer	0.000393	0.00177	CcSEcCtD
Testosterone Propionate—AR—Coregulation of Androgen receptor activity—AKT1—colon cancer	0.000388	0.00311	CbGpPWpGaD
Testosterone Propionate—Hypersensitivity—Methotrexate—colon cancer	0.000367	0.00165	CcSEcCtD
Testosterone Propionate—Asthenia—Methotrexate—colon cancer	0.000357	0.00161	CcSEcCtD
Testosterone Propionate—UGT1A1—Metabolism—CHST5—colon cancer	0.000354	0.00283	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—ODC1—colon cancer	0.000354	0.00283	CbGpPWpGaD
Testosterone Propionate—Pruritus—Methotrexate—colon cancer	0.000352	0.00158	CcSEcCtD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—CASP3—colon cancer	0.000347	0.00278	CbGpPWpGaD
Testosterone Propionate—Diarrhoea—Methotrexate—colon cancer	0.00034	0.00153	CcSEcCtD
Testosterone Propionate—AR—SIDS Susceptibility Pathways—CASP3—colon cancer	0.000338	0.00271	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—CCND1—colon cancer	0.000338	0.0027	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—CTNNB1—colon cancer	0.000334	0.00268	CbGpPWpGaD
Testosterone Propionate—Hydrocortisone—ABCB1—colon cancer	0.000334	0.0962	CrCbGaD
Testosterone Propionate—Dizziness—Methotrexate—colon cancer	0.000329	0.00148	CcSEcCtD
Testosterone Propionate—AR—SIDS Susceptibility Pathways—CTNNB1—colon cancer	0.000326	0.00261	CbGpPWpGaD
Testosterone Propionate—Vomiting—Methotrexate—colon cancer	0.000316	0.00142	CcSEcCtD
Testosterone Propionate—Rash—Methotrexate—colon cancer	0.000314	0.00141	CcSEcCtD
Testosterone Propionate—Dermatitis—Methotrexate—colon cancer	0.000313	0.00141	CcSEcCtD
Testosterone Propionate—Headache—Methotrexate—colon cancer	0.000312	0.0014	CcSEcCtD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—EP300—colon cancer	0.000311	0.00249	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—PTGS2—colon cancer	0.00031	0.00248	CbGpPWpGaD
Testosterone Propionate—AR—Regulation of nuclear SMAD2/3 signaling—AKT1—colon cancer	0.000309	0.00248	CbGpPWpGaD
Testosterone Propionate—AR—SIDS Susceptibility Pathways—EP300—colon cancer	0.000303	0.00243	CbGpPWpGaD
Testosterone Propionate—Nausea—Methotrexate—colon cancer	0.000296	0.00133	CcSEcCtD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—VEGFA—colon cancer	0.000294	0.00236	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—CASP3—colon cancer	0.000287	0.0023	CbGpPWpGaD
Testosterone Propionate—AR—SIDS Susceptibility Pathways—VEGFA—colon cancer	0.000287	0.0023	CbGpPWpGaD
Testosterone Propionate—AR—Androgen receptor signaling pathway—AKT1—colon cancer	0.000287	0.0023	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—CCND1—colon cancer	0.00028	0.00224	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—CTNNB1—colon cancer	0.000277	0.00222	CbGpPWpGaD
Testosterone Propionate—Progesterone—ABCB1—colon cancer	0.000272	0.0784	CrCbGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—MYC—colon cancer	0.000271	0.00217	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—CDKN1A—colon cancer	0.000271	0.00217	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—EGFR—colon cancer	0.000265	0.00212	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—EP300—colon cancer	0.000258	0.00206	CbGpPWpGaD
Testosterone Propionate—Testosterone—ABCB1—colon cancer	0.000257	0.0741	CrCbGaD
Testosterone Propionate—COMT—Transmission across Chemical Synapses—HRAS—colon cancer	0.000252	0.00202	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—SRC—colon cancer	0.00025	0.00201	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—KRAS—colon cancer	0.00025	0.002	CbGpPWpGaD
Testosterone Propionate—UGT1A1—NRF2 pathway—TGFB1—colon cancer	0.000247	0.00197	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—VEGFA—colon cancer	0.000244	0.00195	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—PPARG—colon cancer	0.000233	0.00187	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—MYC—colon cancer	0.000224	0.0018	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—TGFB1—colon cancer	0.000224	0.00179	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—TP53—colon cancer	0.000222	0.00178	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—EGFR—colon cancer	0.000219	0.00176	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—HNF4A—colon cancer	0.000217	0.00174	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—KRAS—colon cancer	0.000207	0.00166	CbGpPWpGaD
Testosterone Propionate—AR—Generic Transcription Pathway—PPARG—colon cancer	0.000196	0.00157	CbGpPWpGaD
Testosterone Propionate—COMT—Neuronal System—HRAS—colon cancer	0.000193	0.00155	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—PIK3CA—colon cancer	0.000191	0.00153	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—AKT1—colon cancer	0.000188	0.0015	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—TP53—colon cancer	0.000184	0.00148	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	0.000184	0.00147	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—ABCB1—colon cancer	0.000156	0.00125	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	0.000156	0.00125	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—TYMS—colon cancer	0.000153	0.00123	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—EP300—colon cancer	0.000153	0.00122	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—ABCB1—colon cancer	0.000149	0.0012	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—TYMS—colon cancer	0.000147	0.00118	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	0.000113	0.000905	CbGpPWpGaD
Testosterone Propionate—AR—Generic Transcription Pathway—MYC—colon cancer	0.000111	0.000893	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—PPARG—colon cancer	0.000109	0.000869	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—PPARG—colon cancer	0.000104	0.000833	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—PPARG—colon cancer	9.41e-05	0.000754	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—ABCB1—colon cancer	9.35e-05	0.000749	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—TYMS—colon cancer	9.18e-05	0.000735	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—PTGS2—colon cancer	8.54e-05	0.000684	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—PTGS2—colon cancer	8.18e-05	0.000655	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—EP300—colon cancer	7.1e-05	0.000569	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—EP300—colon cancer	6.8e-05	0.000545	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—PPARG—colon cancer	6.5e-05	0.000521	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—MYC—colon cancer	5.37e-05	0.00043	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—PIK3CA—colon cancer	5.25e-05	0.000421	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—PTGS2—colon cancer	5.12e-05	0.00041	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—PIK3CA—colon cancer	5.03e-05	0.000403	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—AKT1—colon cancer	4.29e-05	0.000344	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—EP300—colon cancer	4.26e-05	0.000341	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—AKT1—colon cancer	4.11e-05	0.000329	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—AKT1—colon cancer	3.72e-05	0.000298	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—PIK3CA—colon cancer	3.15e-05	0.000252	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—AKT1—colon cancer	2.57e-05	0.000206	CbGpPWpGaD
